News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,273 Results
Type
Article (41886)
Company Profile (261)
Press Release (671125)
Multimedia
Podcasts (58)
Webinars (14)
Section
Business (206445)
Career Advice (2041)
Deals (35767)
Drug Delivery (95)
Drug Development (81507)
Employer Resources (172)
FDA (16377)
Job Trends (15077)
News (348864)
Policy (33062)
Tag
Academia (2638)
Academic (1)
Accelerated approval (9)
Adcomms (22)
Allergies (96)
Alliances (50377)
ALS (108)
Alzheimer's disease (1451)
Antibody-drug conjugate (ADC) (151)
Approvals (16374)
Artificial intelligence (310)
Autoimmune disease (28)
Automation (18)
Bankruptcy (365)
Best Places to Work (11706)
BIOSECURE Act (19)
Biosimilars (120)
Biotechnology (180)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (363)
Cancer (2858)
Cardiovascular disease (213)
Career advice (1710)
Career pathing (31)
CAR-T (183)
CDC (30)
Cell therapy (495)
Cervical cancer (23)
Clinical research (67015)
Collaboration (1020)
Company closure (3)
Compensation (680)
Complete response letters (21)
COVID-19 (2674)
CRISPR (57)
C-suite (324)
Cystic fibrosis (111)
Data (2978)
Decentralized trials (2)
Denatured (20)
Depression (58)
Diabetes (347)
Diagnostics (6595)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (136)
Drug pricing (120)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87885)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (114522)
Executive appointments (851)
FDA (18018)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (936)
Gene editing (131)
Generative AI (22)
Gene therapy (373)
GLP-1 (789)
Government (4547)
Grass and pollen (4)
Guidances (181)
Healthcare (18974)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (147)
Immuno-oncology (8)
Indications (39)
Infectious disease (2849)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (63)
Intellectual property (119)
Interviews (316)
IPO (16662)
IRA (44)
Job creations (3758)
Job search strategy (1451)
Kidney cancer (13)
Labor market (52)
Layoffs (494)
Leadership (19)
Legal (8047)
Liver cancer (79)
Lung cancer (402)
Lymphoma (207)
Machine learning (11)
Management (58)
Manufacturing (381)
MASH (91)
Medical device (13524)
Medtech (13529)
Mergers & acquisitions (19818)
Metabolic disorders (848)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (114)
Neuropsychiatric disorders (31)
Neuroscience (2121)
NextGen: Class of 2025 (6554)
Non-profit (4544)
Now hiring (47)
Obesity (426)
Opinion (220)
Ovarian cancer (100)
Pain (104)
Pancreatic cancer (121)
Parkinson's disease (187)
Partnered (22)
Patents (295)
Patient recruitment (160)
Peanut (51)
People (58315)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20900)
Phase II (29501)
Phase III (21958)
Pipeline (1625)
Policy (197)
Postmarket research (2584)
Preclinical (8982)
Press Release (67)
Prostate cancer (140)
Psychedelics (35)
Radiopharmaceuticals (254)
Rare diseases (455)
Real estate (6129)
Recruiting (66)
Regulatory (22925)
Reports (50)
Research institute (2387)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (157)
Series B (106)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (149)
Sponsored (35)
Startups (3633)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (57)
The Weekly (36)
Vaccines (781)
Venture capital (53)
Weight loss (256)
Women's health (45)
Worklife (16)
Date
Last 7 days (368)
Last 30 days (1795)
Last 365 days (31315)
2025 (16689)
2024 (35421)
2023 (40336)
2022 (51426)
2021 (56014)
2020 (54491)
2019 (46959)
2018 (35322)
2017 (32506)
2016 (31974)
2015 (38000)
2014 (31857)
2013 (26979)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (736)
Alabama (61)
Alaska (7)
Arizona (245)
Arkansas (13)
Asia (39008)
Australia (6371)
California (7429)
Canada (2360)
China (671)
Colorado (322)
Connecticut (317)
Delaware (192)
Europe (84117)
Florida (1116)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (638)
India (26)
Indiana (361)
Iowa (16)
Japan (226)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1024)
Massachusetts (5522)
Michigan (245)
Minnesota (452)
Mississippi (3)
Missouri (95)
Montana (31)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2075)
New Mexico (29)
New York (2088)
North Carolina (1095)
North Dakota (8)
Northern California (3262)
Ohio (240)
Oklahoma (16)
Oregon (34)
Pennsylvania (1611)
Puerto Rico (17)
Rhode Island (36)
South America (1128)
South Carolina (34)
South Dakota (1)
Southern California (2778)
Tennessee (125)
Texas (1120)
United States (27576)
Utah (221)
Virginia (182)
Washington D.C. (72)
Washington State (632)
West Virginia (4)
Wisconsin (66)
713,273 Results for "prometheus laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
July 3, 2025
·
1 min read
Business
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing
Prometheus Laboratories Inc. today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO (adalimumab-aacf).
August 1, 2023
·
3 min read
Biotech Beach
Prometheus Laboratories Announces the Launch of PredictrPK ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab
Prometheus Laboratories Inc. announced the launch of PredictrPK ADA, a precision-guided dosing test for adult Crohn’s disease (CD) patients receiving ADA treatment.
July 27, 2023
·
4 min read
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
Biotech Beach
Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBD
Prometheus Laboratories Inc. (“Prometheus”), a leader in precision healthcare, announced the launch of an induction-phase indication for PredictrPK IFX, a precision-guided dosing test.
March 2, 2023
·
4 min read
Press Releases
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
November 14, 2024
·
6 min read
1 of 71,328
Next
